Subscription: Free

Glenmark Pharmaceuticals Limited is a strong BUY at ₹1938 with a target price of ₹2131 and stop loss at ₹1745. The company has recently delivered robust Q1FY26 results, showcasing over 120% growth in revenues, supported by solid demand in the US and Indian markets. Expansion in specialty and generics segments, along with a healthy product…

The stock has been in upward momentum and current consolidation is pause. Results for Q1FY26 were excellent and thus it finds fundamental support and a catalyst to sustain momentum as well. The current range is indicating signs of breakout and hence a buy with strict stoploss is recommended.  

Technical/ momentum buy – One can buy stock between 290-300 for a target of 337 and stop loss of 282. RR of 1:2 Stock has been in good momentum with continuous insider buying (Aditya Kunar Halwasiya) at various levels holding overall 17.92% stake as at Jun25 end.  

NMDC Steel Limited presents a strong buying opportunity at ₹43, supported by robust fundamentals and improving market sentiment in the steel sector. The company benefits from its integrated operations, access to low-cost raw materials, and backing from NMDC Ltd., ensuring steady supply and cost efficiency. Recent capacity utilization improvements and strategic expansion plans enhance revenue…